Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Cinacalcet on Arterial Stiffness in Hemodialysis
NCT01250405Phase 4
Key facts
- Status
- Completed
- Start
- May 2012
- Primary completion
- Apr 2014
- Countries
- 1
- Sponsor
- Université Laval
- Modality
- Small Molecules
- Drugs
- cinacalcet
- Conditions
- secondary hyperparathyroidism (SHPT)
01
Overview
Phase 4, randomised, double-blind trial in secondary hyperparathyroidism (SHPT) comparing Cinacalcet Sequence with Placebo Sequence (2 arms). Primary endpoint: Carotid-Femoral Pulse Wave Velocity at 1 week. Started May 2012; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Cinacalcet Sequence
Cinacalcet 30mg/d for 7 days followed by Placebo for 7 days
Placebo Sequence
Placebo for 7 days followed by Cinacalcet 30mg/d for 7 days
03
Endpoints
Primary
Carotid-Femoral Pulse Wave Velocity
Secondary
Carotid-Radial Pulse Wave Velocity
Common Carotid Artery Biomechanics
Pulse Wave Profile
Ventricular Function
Beyond the preview
Go deeper on NCT01250405.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250405.